125 related articles for article (PubMed ID: 35736371)
1. [The treatment of stable coronary artery disease: always optimal medical therapy, coronary revascularization only on indication].
van den Brink RBA; Verheul HA
Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736371
[TBL] [Abstract][Full Text] [Related]
2. Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials.
Galli M; Vescovo GM; Andreotti F; D'Amario D; Leone AM; Benenati S; Vergallo R; Niccoli G; Trani C; Porto I
Minerva Cardiol Angiol; 2023 Apr; 71(2):221-229. PubMed ID: 33944534
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
[TBL] [Abstract][Full Text] [Related]
4. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
[TBL] [Abstract][Full Text] [Related]
5. Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease.
Taglieri N; Bruno AG; Bacchi Reggiani ML; D'Angelo EC; Ghetti G; Bruno M; Palmerini T; Rapezzi C; Galiè N; Saia F
Int J Cardiol; 2020 Jun; 309():63-69. PubMed ID: 32037130
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
7. Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
Kawashima H; Serruys PW; Ono M; Hara H; O'Leary N; Mack MJ; Holmes DR; Morice MC; Head SJ; Kappetein AP; Thuijs DJFM; Milojevic M; Noack T; Mohr FW; Davierwala PM; Sharif F; McEvoy JW; Onuma Y;
J Am Coll Cardiol; 2021 Jul; 78(1):27-38. PubMed ID: 34210411
[TBL] [Abstract][Full Text] [Related]
8. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
Navarese EP; Lansky AJ; Kereiakes DJ; Kubica J; Gurbel PA; Gorog DA; Valgimigli M; Curzen N; Kandzari DE; Bonaca MP; Brouwer M; Umińska J; Jaguszewski MJ; Raggi P; Waksman R; Leon MB; Wijns W; Andreotti F
Eur Heart J; 2021 Dec; 42(45):4638-4651. PubMed ID: 34002203
[TBL] [Abstract][Full Text] [Related]
9. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
[TBL] [Abstract][Full Text] [Related]
10. Predictors and Outcomes of Routine Versus Optimal Medical Therapy in Stable Coronary Heart Disease.
Chun S; Qiu F; Austin PC; Ko DT; Mamdani M; Wijeysundera DN; Czarnecki A; Bennell MC; Wijeysundera HC
Am J Cardiol; 2015 Sep; 116(5):671-7. PubMed ID: 26119653
[TBL] [Abstract][Full Text] [Related]
11. Optimal medical therapy in patients with stable coronary artery disease in Poland: the ISCHEMIA trial experience.
Pracoń R; Demkow M; Anthopolos R; Mazurek T; Drożdż J; Witkowski A; Gajos G; Pruszczyk P; Roik M; Łoboz-Grudzień K; Lesiak M; Reczuch K; Kalarus Z; Kryczka K; Henzel J; Kaczmarska-Dyrda E; Maksym J; Jonik S; Krekora J; Celińska-Spodar M; Jaroch J; Łanocha M; Szulik M; Szwed H; Rużyłło W
Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34585554
[TBL] [Abstract][Full Text] [Related]
12. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
Iqbal J; Zhang YJ; Holmes DR; Morice MC; Mack MJ; Kappetein AP; Feldman T; Stahle E; Escaned J; Banning AP; Gunn JP; Colombo A; Steyerberg EW; Mohr FW; Serruys PW
Circulation; 2015 Apr; 131(14):1269-77. PubMed ID: 25847979
[TBL] [Abstract][Full Text] [Related]
13. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
[TBL] [Abstract][Full Text] [Related]
14. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R
Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173
[TBL] [Abstract][Full Text] [Related]
16. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
[TBL] [Abstract][Full Text] [Related]
17. Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
Laukkanen JA; Kunutsor SK
Int J Cardiol; 2021 Feb; 324():13-21. PubMed ID: 33068645
[TBL] [Abstract][Full Text] [Related]
18. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
19. The State of Percutaneous Intervention in Stable Coronary Artery Disease.
Drescher C; Rao SV
Curr Atheroscler Rep; 2020 Jul; 22(8):42. PubMed ID: 32671483
[TBL] [Abstract][Full Text] [Related]
20. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
Zhang F; Dong L; Ge J
Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
